ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,192Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 257

$1.85M Total Retail Price of All Prescriptions

Rank: 16 out of 257

511 Patients Receiving at Least One Drug in Part D
64% Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

30% of this provider’s 511 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

45% of this provider’s 511 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$181 was the average price of a prescription from this provider, compared to $218 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,147 515 192 S3 1 3
PREDNISONE 436 267 107 2 1
ALPRAZOLAM 375 138 67 B 3 25
ZOLPIDEM TARTRATE 262 158 46 4 19
MELOXICAM 255 154 57 5 8
METHYLPREDNISOLONE 233 166 88 6 24
METHOTREXATE 216 168 47 7 2
LYRICA 198 101 38 8 12
CARISOPRODOL 191 66 31 R 9 32
HYDROXYCHLOROQUINE SULFATE 184 95 41 10 4
GABAPENTIN 165 80 52 11 6
OMEPRAZOLE 163 121 32 12 18
TRAMADOL HCL 150 116 53 13 5
MORPHINE SULFATE ER 141 44 32 S2 14 76
METHADONE HCL 133 54 31 S2 15 93
CYMBALTA 130 70 37 16 10
NABUMETONE 117 42 25 17 27
NEXIUM 114 52 22 18 37
CYCLOBENZAPRINE HCL 109 50 27 R 19 16
IBUPROFEN 107 43 33 20 49
HYDROMORPHONE HCL* 98 14 23 S2 21 131
FENTANYL 98 41 24 S2 21 43
ENBREL 96 28 11 23 9
TRIAMTERENE-HCTZ 94 40 25 24 106
CELEBREX 93 62 26 25 13
ATELVIA 92 71 24 26 28
DIAZEPAM 85 43 18 B 27 141
LEVOTHYROXINE SODIUM 81 35 22 28 21
DICLOFENAC SODIUM 81 68 20 28 33
CIPROFLOXACIN HCL 78 32 31 30 103
ACETAMINOPHEN-CODEINE 77 59 30 S3 31 75
NAPROXEN 76 51 17 32 29
TEMAZEPAM 76 40 18 B 32 65
LANSOPRAZOLE 74 <11 <11 34 182
LEFLUNOMIDE 73 47 18 35 7
SERTRALINE HCL 70 32 14 36 55
AMITRIPTYLINE HCL 67 20 13 R 37 47
OXYCODONE-ACETAMINOPHEN 62 14 14 S2 38 161
ZOLPIDEM TARTRATE ER 62 <11 <11 38 194
FLUOXETINE HCL 59 30 13 40 104
VENLAFAXINE HCL ER 59 41 12 40 117
PAROXETINE HCL 59 13 11 40 136
CLONAZEPAM 58 20 15 B 43 52
TRAZODONE HCL 57 19 14 44 51
FUROSEMIDE 57 40 16 44 44
TIZANIDINE HCL 56 17 15 46 20
LORAZEPAM 53 <11 13 B 47 82
AVINZA 53 19 12 S2 47 220
AMPHETAMINE SALT COMBO 52 <11 12 S2 49 158
ESCITALOPRAM OXALATE 51 25 13 50 92
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2015.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.